Skip to main content
Caplight Logo









CoMind

CoMind

Private
LondonHealthcare & Life Scienceshttps://www.comind.io/

Last Round

Series A

Extension

Oct 20, 2025

Total Funding Raised

$102.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

CoMind is a neurotechnology company that develops non-invasive brain-computer interfaces and optical neuromonitoring devices designed to monitor neurological parameters and improve patient outcomes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

neurotechnologybrain monitoringbrain-computer interfaceBCInon-invasive monitoringmedical deviceintracranial pressureICPcerebral blood flowCBFhealth IoTclinical diagnosticsmedical AIwearable neurotechneuromonitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CoMind Comparables

Compare CoMind with similar companies based on industry and business-model similarity.

CoMind comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kernel
84%
Emotiv
78%
Artinis Medical Systems
77%

CoMind Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionOct 20, 2025
Series ANov 1, 2023
GrantJan 6, 2022

Key People

Founding team and executive leadership

James Dacombe

Founder, CEO

Founding Team

Simon Morling

Chief Technology Officer

Executive Team

CoMind Investors

Notable investors and investment history

CoMind investors
InvestorRounds
Backed VCSeries A Extension
LocalGlobeSeries A Extension
Latitude VenturesSeries A Extension
Angelini VenturesSeries A Extension, Series A
Phoenix Court GroupSeries A Extension, Seed
LocalGlobeSeries A Extension
Thiel FellowshipGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 30% MoM, reaching 9.7K.

  • Mar 30, 2026

    Neuromonitoring tech in clinical trials, developing FDA software.

Recent news

Latest coverage and updates

  • receives_financingAug 4, 2026

    CoMind Technologies Limited received financing of $138M in funding round on Jul 1st '25.

CoMind Filings

Explore SEC and related filing metadata, where available.

CoMind filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CoMind's valuation, stock price, and market status.

Is CoMind a public or private company?

CoMind is a private company.

What is the current stock price of CoMind?

CoMind is a private company with no public stock price. No recent secondary market data is available.

How much is CoMind worth (valuation)?

Valuation information for CoMind is not publicly available.

Can I buy CoMind stock?

CoMind shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CoMind's last funding round?

CoMind's most recent funding round was Series A on October 20, 2025.

Who are the main investors in CoMind?

Key investors in CoMind include Plural.

Will CoMind IPO soon?

No public IPO plans have been announced for CoMind.

How can I track CoMind secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CoMind's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range72
Year Founded2018
Last FundingOct 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?